ClinVar Miner

Submissions for variant NM_003002.4(SDHD):c.170-29A>G

gnomAD frequency: 0.11431  dbSNP: rs9919624
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001672822 SCV000605083 benign not provided 2020-03-10 criteria provided, single submitter clinical testing
GeneDx RCV001672822 SCV001884299 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001807283 SCV002054700 benign Mitochondrial complex 2 deficiency, nuclear type 3 2021-07-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001807282 SCV002054701 benign Paragangliomas 1 2021-07-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001807281 SCV002054702 benign Pheochromocytoma 2021-07-15 criteria provided, single submitter clinical testing
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV002268135 SCV002549993 likely benign not specified 2023-08-15 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV003316658 SCV004015425 benign Paragangliomas 3 2023-07-07 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV001672822 SCV005231593 benign not provided criteria provided, single submitter not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.